Light Day Sunscreen Spf 37 Lotion
NDC Package 76458-301-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Light Day Sunscreen Spf 37 (avobenzone, octinoxate, octocrylene) lotions is • apply liberally to skin 15 minutes before sun exposure. This formulation utilizes a lotion delivery system. Marketed by Circadia By Dr Pugliese, Inc., this product is identified by NDC 76458-301 and is authorized under FDA application M020.

Identification & Billing

NDC Package Code
76458-301-08
Package Description
236 mL in 1 BOTTLE
Product Code
76458-301
11-Digit Billing Format
76458030108

Clinical Specifications

Proprietary Name
Light Day Sunscreen Spf 37
Non-Proprietary Name
Avobenzone, Octinoxate, Octocrylene
Substance Name
Avobenzone; Octinoxate; Octocrylene
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
• apply liberally to skin 15 minutes before sun exposure. • use a water resistant sunscreen if swimming or sweating. • reapply at least every 2 hours. • children under 6 months: Ask a doctor. • Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF15 or higher and other sun protection measures including: • limit time in the sun, especially from 10 a.m. - 2 p.m. • wear long-sleeved shirt, pants, hats, a nd sunglasses.

Regulatory & Marketing

Labeler Name
Circadia By Dr Pugliese, Inc.
Product Type
Human Otc Drug
FDA Application #
M020
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-14-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (76458-301). Click a package code to view its specific billing and regulatory data.

76458-301-02
1 BOTTLE in 1 BOX / 59 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 76458-301-08 identifies a specific commercial package of 236 ml in 1 bottle of Light Day Sunscreen Spf 37, a human over the counter drug labeled by Circadia By Dr Pugliese, Inc.. This lotion is formulated for topical use and contains avobenzone; octinoxate; octocrylene as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Circadia By Dr Pugliese, Inc. on February 14, 2020. The current certification is valid through December 31, 2026.

How is this Circadia By Dr Pugliese, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 76458030108. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
76458-301-08
11-Digit CMS (5-4-2)
76458-0301-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.